back to overview

press

Whitepaper: A positive prognosis for the future of healthtech

December 16, 2019 + Jessica Di Palo
7 Min read

The healthcare industry is in the midst of a se a change, inspired by the urgent demand for lower cost, higher quality strategies that improve and extend lives. This has, in turn, fostered growing support for a more sustainable healthcare framework, where incentives are oriented toward prevention and quality of care rather than higher volumes and post-diagnosis treatment.

whitepaper future of healthcare

The healthcare industry is in the midst of a sea change, inspired by the urgent demand for lower cost, higher quality strategies that improve and extend lives. This has, in turn, fostered growing support for a more sustainable healthcare framework, where incentives are oriented toward prevention and quality of care rather than higher volumes and post-diagnosis treatment. Further bolstered by an array of economic, demographic and other factors, as well as major technological advances and converging stakeholder interests, the result has been a broad search for digitally-connected, decentralized and patient-centric solutions. With traditional industry players, technology giants, and private equity and other financial operators rushing to join the fray, the healthtech revolution looks to be an investment opportunity-in-the-making.

Share the Article

blog blog blog blog blog blog blog blog blog blog

Pioneering the use of machine learning algorithms to turbo-charge drug development

Intelligencia revolutionizes drug development

The psychology of decision making

What makes a good investor?

Revolutionizing medical triage with artificial intelligence

Mediktor's solution for medical triage

MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments

MTIP Fund II is closed!

Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics

Cynerio's new product Cynerio Now!

MTIP invests in Mediktor

New investment in Mediktor

SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right

MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round

MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia

Private Equity 101: Part one – Glossary

Are you new to the healthtech space?

Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey

Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations

MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II

How to pitch to a healthtech Investor

Blog Pitching

MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health

MTIP scored fantastic grades in the UNPRI assessment report of 2020

UNPRI Report grades 2020

press

4 Health VCs Share Their Business Priorities and What is Next

Interview Techtour

MTIP invests in Trialbee

New investment in Trialbee

TytoCare closes $50 million round as the demand for telehealth accelerates

TytoCare closes new round

The digital healthtech sector is expanding – and so are we!

Two new empolyees start in April

news news news news news news news news news news news news news

MTIP has sucessfully exited Blueprint Genetics

Blueprint exit January 2020

New MTIP investment in Oviva

New investment in Oviva

press

Whitepaper: A positive prognosis for the future of healthtech

Our first Whitepaper